<?xml version='1.0' encoding='utf-8'?>
<document id="20934550"><sentence text="Dronedarone and vitamin K antagonists: a review of drug-drug interactions."><entity charOffset="0-11" id="DDI-PubMed.20934550.s1.e0" text="Dronedarone" /><entity charOffset="16-25" id="DDI-PubMed.20934550.s1.e1" text="vitamin K" /><pair ddi="false" e1="DDI-PubMed.20934550.s1.e0" e2="DDI-PubMed.20934550.s1.e0" /><pair ddi="false" e1="DDI-PubMed.20934550.s1.e0" e2="DDI-PubMed.20934550.s1.e1" /></sentence><sentence text="Adverse drug events affect millions of patients each year" /><sentence text=" An important drug-drug interaction between amiodarone and vitamin K antagonists is encountered frequently in daily clinical practice"><entity charOffset="44-54" id="DDI-PubMed.20934550.s3.e0" text="amiodarone" /><entity charOffset="59-68" id="DDI-PubMed.20934550.s3.e1" text="vitamin K" /><pair ddi="false" e1="DDI-PubMed.20934550.s3.e0" e2="DDI-PubMed.20934550.s3.e0" /><pair ddi="false" e1="DDI-PubMed.20934550.s3.e0" e2="DDI-PubMed.20934550.s3.e1" /></sentence><sentence text=" Warfarin, a commonly used anticoagulant, is a mixture of 2 optically active isomers (R and S enantiomers)"><entity charOffset="1-9" id="DDI-PubMed.20934550.s4.e0" text="Warfarin" /></sentence><sentence text=" The S enantiomer is approximately 3 times more potent than the R enantiomer and is metabolized primarily by CYP2C9"><entity charOffset="5-6" id="DDI-PubMed.20934550.s5.e0" text="S" /></sentence><sentence text=" Inhibition of CYP2C9 by amiodarone and its major metabolite potentiates the anticoagulant effects of warfarin, increasing the risk of serious bleeding"><entity charOffset="25-35" id="DDI-PubMed.20934550.s6.e0" text="amiodarone" /></sentence><sentence text=" In contrast, dronedarone, a synthetic derivative of amiodarone the structure of which lacks the iodine moiety, is less likely to cause a drug-drug interaction with warfarin"><entity charOffset="14-25" id="DDI-PubMed.20934550.s7.e0" text="dronedarone" /><entity charOffset="53-63" id="DDI-PubMed.20934550.s7.e1" text="amiodarone" /><entity charOffset="97-103" id="DDI-PubMed.20934550.s7.e2" text="iodine" /><entity charOffset="165-173" id="DDI-PubMed.20934550.s7.e3" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e0" e2="DDI-PubMed.20934550.s7.e0" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e0" e2="DDI-PubMed.20934550.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e0" e2="DDI-PubMed.20934550.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e0" e2="DDI-PubMed.20934550.s7.e3" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e1" e2="DDI-PubMed.20934550.s7.e1" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e1" e2="DDI-PubMed.20934550.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e1" e2="DDI-PubMed.20934550.s7.e3" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e2" e2="DDI-PubMed.20934550.s7.e2" /><pair ddi="false" e1="DDI-PubMed.20934550.s7.e2" e2="DDI-PubMed.20934550.s7.e3" /></sentence><sentence text=" Accordingly, dronedarone may be a particularly attractive antiarrhythmic choice among patients with atrial fibrillation who are also being treated with warfarin"><entity charOffset="14-25" id="DDI-PubMed.20934550.s8.e0" text="dronedarone" /><entity charOffset="153-161" id="DDI-PubMed.20934550.s8.e1" text="warfarin" /><pair ddi="false" e1="DDI-PubMed.20934550.s8.e0" e2="DDI-PubMed.20934550.s8.e0" /><pair ddi="false" e1="DDI-PubMed.20934550.s8.e0" e2="DDI-PubMed.20934550.s8.e1" /></sentence><sentence text="" /></document>